as on December 24, 2025 at 2:29 am IST
Day's Low
Day's High
0.96%
Downside
1.00%
Upside
52 Week's Low
52 Week's High
47.32%
Downside
18.15%
Upside
Check Veracyte, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.4B
EPS (TTM)
1.6457
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.26%
PE Ratio (TTM)
112.95
Industry PE ratio
7.725789473684211
PEG Ratio
0EBITDA
73.7M
Revenue (TTM)
495.1M
Profit Margin
6.12%
Return On Equity TTM
2.49%
Track how Veracyte, Inc. P/E has moved over time to understand its valuation trends.
Veracyte, Inc. in the last 5 years
Lowest (-187.55x)
September 30, 2024
Industry (7.73x)
December 24, 2025
Today (112.95x)
December 24, 2025
Highest (63.11x)
December 31, 2024
Today’s Price to Earnings Ratio: 112.95x
Compare market cap, revenue, PE, and other key metrics of Veracyte, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $3.4B | -23.08% | 112.95 | 6.12% | |
| BUY | $56.2B | 37.25% | 55.55 | 24.65% | |
| BUY | $38.3B | 27.97% | 30.97 | 8.07% | |
| BUY | $216.3B | 26.6% | 33.22 | 15.02% | |
| BUY | $39.3B | 17.94% | 30.05 | 18.75% |
The Veracyte, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Veracyte, Inc. investment value today
Current value as on today
₹1,09,482
Returns
₹9,482
(+9.48%)
Returns from Veracyte, Inc. Stock
₹4,225 (+4.23%)
Dollar Returns*
₹5,256 (+5.26%)
Based on 15 analysts
73.33%
Buy
20.00%
Hold
6.67%
Sell
Based on 15 analysts, 73.33% of analysts recommend a 'BUY' rating for Veracyte, Inc.. Average target price of $47.5
Get share price movements and forecasts by analysts on Veracyte, Inc..
What analysts predicted
9.64%UPSIDE
Target Price
$47.5
Current Price
$42.92
Analyzed by
15 Analysts
Target
$47.50
Veracyte, Inc. target price $47.5, a slight upside of 9.64% compared to current price of $42.92. According to 15 analysts rating.
Search interest for Veracyte, Inc. Stock has decreased by -3% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 05 November
Wed, 11:28 PM
-Veracyte shares surged 26% after Q3 earnings of 51 cents exceeded expectations, with revenue also surpassing estimates.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 3 months, VCYT stock has moved up by 31.3%
Best in 3 Years
![]()
In the last 3 years, VCYT has outperformed top 5 stocks with highest market-cap in its industry
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -980.0K → 19.13M (in $), with an average increase of 105.1% per quarter
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 114.47M → 131.87M (in $), with an average increase of 6.7% per quarter
Against Peers
![]()
In the last 1 year, Idexx Laboratories, Inc. has given 65.0% return, outperforming this stock by 60.8%
| Organisation | Veracyte, Inc. |
| Headquarters | 6000 Shoreline Court, South San Francisco, CA, United States, 94080 |
| Industry | Health Technology |
| CEO | Mr. Marc A. Stapley |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Marc A. Stapley | CEO & Director |
Dr. Phillip G. Febbo M.D. | Chief Scientific & Medical Officer |
Ms. Annie McGuire | Executive VP, General Counsel & Chief People Officer |
Ms. Karen Possemato | Senior Vice President of Corporate Marketing, Communications & Commercial Operations |
Ms. Corinne Danan | Senior Vice President |
Ms. Rebecca Chambers | Executive VP & CFO |
Dr. John Leite Ph.D. | Global Chief Commercial Officer |
Dr. Keith Gligorich Ph.D. | Senior Vice President of Global Operations |
Mr. Jonathan Wygant | VP & Chief Accounting Officer |
Mr. Steven French | Senior VP & Chief Information Officer |
Veracyte, Inc. share price today is $42.92 as on at the close of the market. Veracyte, Inc. share today touched a day high of $43.35 and a low of $42.51.
Veracyte, Inc. share touched a 52 week high of $50.71 on and a 52 week low of $22.61 on . Veracyte, Inc. stock price today i.e. is closed at $42.92,which is 15.36% down from its 52 week high and 89.83% up from its 52 week low.
Veracyte, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Veracyte, Inc. (VCYT) shares with as little as ₹89.573 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹895.73 in Veracyte, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Veracyte, Inc. share’s latest price of $42.92 as on December 24, 2025 at 2:29 am IST, you will get 0.2330 shares of Veracyte, Inc.. Learn more about
fractional shares .
Veracyte, Inc. stock has given -23.08% share price returns and 21.45% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?